Blockade of CD40 Ligand-CD40 Interaction Impairs CD4+ T Cell-Mediated Alloreactivity by Inhibiting Mature Donor T Cell Expansion and Function after Bone Marrow Transplantation

Journal of Immunology

Volumn 158, Issue 1, 1997, Pages 29-39

  Blazar, Bruce R ^a,f   Taylor, Patricia A ^a   Panoskaltsis Mortari, Angela ^a   Buhlman, Janet ^c   Xu, Jianchao ^d   Flavell, Richard A ^d   Korngold, Robert ^e   Noelle, Randolph ^c   Vallera, Daniel A ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

^f UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CD40 ANTIGEN; CD40 LIGAND; LIGAND; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY;

ANIMAL; ARTICLE; BINDING COMPETITION; BONE MARROW TRANSPLANTATION; C57BL MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOTOXICITY; DRUG ANTAGONISM; DRUG EFFECT; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOUSE; MOUSE MUTANT; MOUSE STRAIN; PATHOLOGY; PROTEIN BINDING;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; BINDING, COMPETITIVE; BONE MARROW TRANSPLANTATION; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; ISOANTIGENS; LIGANDS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, SCID; PROTEIN BINDING;

EID: 0030639082     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Jenkins, M. K., and R. H. Schwartz. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165:302.
2. Schwartz, R. H. 1992. Costimulation of T lymphocytes: the role of CD28. CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71: 1065.
3. June, C. H., J. A. Bluestone, L. M. Nadler, and C. B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321.
4. Freeman, G. J., J. G. Gribben, V. A. Boussiotis, J. Ng, V. Restivo, L. Lombard, G. S. Gray, and L. M. Nadler. 1993. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262:909.
5. Lenschow, D. J., G. H. Su, L. A. Zuckerman, N. Nabavi, C. L. Jellis, G. S. Gray, J. Miller, and J. A. Bluestone. 1993. Expression and functional significance of an additional ligand for CTLA-4. Proc. Natl. Acad. Sci. USA 90:11054.
6. Stamenkovi, I., E. A. Clark, and B. Seed. 1989. A B-lymphocyte activation molecule related to the nerve growth factor receptor and inducted by cytokines in carcinomas. EMBO J. 8:1403.
7. Clark, E. A., and J. A. Ledbetter. 1986. Activation of human B cells mediated through two distinct cell surface differentiation antigens. Bp35 and Bp50. Proc. Natl. Acad. Sci. USA 83:4494.
8. Hart, D. N. J., and J. L. McKenzie. 1988. Isolation and characterization of human tonsil dendritic cells. J. Exp. Med. 168:157.
9. Schriever, F., A. S. Freedman, G. Freeman, F., Messner, G. Lee, J. Daley, and L. M. Nadler. 1989. Isolated human follicular dendritic cells display a unique antigenic phenotype. J. Exp. Med. 169:2043.
10. Galy, A. H. M., and H. Spits. 1992. CD40 is functionally expressed on human thymic epithelium. J. Immunol. 149:775.
11. Hollenbaugh, D., L. S. Grosmaire, C. D. Kullas, N. J. Chalupny, S. Braesch-Anderson, R. J. Noelle, I. Stamenkovic, J. A. Ledbetter, and A. Aruffo. 1992. The human T cell antigen p39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimultatory activity. EMBO J. 11:4313.
12. Armitage, R. J., W. C. Famslow, L. Strockbine, T. A. Sato, K. N. Clifford, B. M. Macduff, D. M. Anderson, S. D. Gimpel, T. Davis-Smith, C. R. Maliszewski, E. A. Clark, C. A. Smith, K. H. Grabstein, K. Coman, and M. K. Spriggs. 1992. Molecular and biological characterization of a murine ligand for CD40. Nature 357:80.
13. Noelle, R. J., M. Roy, D. M. Sheperd, I. Stamenkovic, J. A. Ledbetter, and A. Aruffo. 1992. A 39-kDa protein on activated helper T cells bind CD40 and transduces the signal for cognate activation of B cells. Proc. Natl. Acad. Sci. USA 89:6550.
14. Lederman, S., M. J. Yellin, G. Inghirami, J. J. Lee, D. M. Knowles, and L. Chess. 1992. Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles: roles of T cell-B cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help. J. Immunol. 149:3817.
15. + T cell clones allow B cell growth and differentiation. Eur. J. Immunol. 25:2972.
16. Grammer, A. C., M. C. Bergman, Y. Miura, K. Fujita, L. S. Davis, and P. E. Lipsky. 1995. The CD40 ligand expressed by human B cells costimulates B cell responses. J. Immunol. 154:4996.
17. Foy, T. M., D. M. Shepherd, F. H. Durie, A. Aruffo, J. A. Ledbetter, and R. J. Noelle. 1993. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J. Exp. Med. 178:1567.
18. Gray, D., P. Dullforce, and S. Jainandunsing. 1994. Memory B cell development but not germinal center formation is impaired by in vivo blockade of CD40-CD40 ligand interaction. J. Exp. Med. 180:141.
19. Kawabe, T., T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara, S. Suematsu, N. Yoshida, T. Kishimoto, and H. Kikutani. 1994. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1:167.
20. Xu, J., T. M. Foy, J. D. Laman, E. A. Elliott, J. J. Dunn, T. J. Waldschmidt, J. Elsemore, R. J. Noelle, and R. A. Flavell. 1994. Mice deficient for the CD40 ligand. Immunity 1:423.
21. Renshaw, B., W. C. Fanslow III, R. J. Armitage, K. A. Campbell, D. Liggitt, B. Wright, B. L. Davison, and C. R. Maliszewski. 1994. Humoral immune responses in CD40 ligand-dencient mice. J. Exp. Med. 180:1889.
22. Allen, R. C., R. J. Armitage, M. E. Conley, H. Rosenblatt, N. A. Jenkins, N. G. Copeland, M. A. Bedell, S. Edelhoff, C. M. Disteche, and D. K. Simoneaux. 1993. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259:990.
23. Armitage, R. J., and M. R. Alderson. B-cell stimulation. 1995. Curr. Opin. Immunol. 7:243.
24. Noelle, R. J. 1996. CD40 and its ligand in host defense. Immunity 4:415.
25. Ranheim, E. A., and T. J. Kipps. 1993. Activated T cells induced expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177:925.
26. Kennedy, M. K., K. M. Mohler, K. D. Shanebeck, P. R. Baum, K. S. Picha, C. A. Otten-Evans, C. A. Janeway, Jr., and K. Grabstein. 1994. Induction of B cell costimulatory function by recombinant murine CD40. Eur. J. Immunol. 24:116.
27. Klaus, S. J., L. M. Pinchuk, H. D. Ochs, C. L. Law, W. C. Fanslow, R. J. Armitage, and E. A. Clark. 1994. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction. J. Immunol. 152:5643.
28. Roy, M., A. Aruffo, J. Ledbetter, P. Linsley, M. Kehry, and R. Noelle. 1995. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Eur. J. Immunol. 25:596.
29. Ding, L., J. M. Green, C. B. Thompson, and E. M. Shevach. 1995. B7/CD28-dependent and -independent induction of CD40 ligand expression. J. Immunol. 155:5124.
30. Jaiswal, A. I., C. Dubey, S. L. Swain, and M. Croft. 1996. Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not co-stimulatory signals. Int. Immunol. 8:275.
31. Buhlmann, J. E., T. M. Foy. A. Aruffo, K. M. Crassi, J. A. Ledbetter, W. R. Green, J. C. Xu, L. D. Shultz, D. Roopenian, R. A. Flavell, L. Fast, R. J. Noelle, and F. H. Durie. 1995. In the absence of a CD40 signal, B cells are tolerogenic. Immunity 2:645.
32. Hollander, G. A., E. Castigli, R. Kulbacki, M. Su, S. J. Burakoff, J.-C. Gutierrez-Ramos, and R. S. Geha. 1996. Proc. Natl. Acad. Sci. USA 4994.
33. Durie, F. H., R. A. Fava, T. M. Foy, A. Aruffo, J. A. Ledbetter, and R. J. Noelle. 1993. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261:1328.
34. Gerritse, K., J. D. Laman, R. J. Noelle, A. Aruffo, J. A. Ledbetter, W. J. A. Boersma, and E. Claassen. 1996. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. USA 93:2499.
35. Parker, D. C., D. L. Greiner, N. E. Phillips, M. C. Appel, A. W. Steele, F. H. Durie, R. J. Noelle, J. P. Mordes, and A. A. Rossini. 1995. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc. Natl. Acad. Sci. USA 92:9560.
36. Durie, F. H., A. Aruffo, J. Ledbetter, K. M. Crassi, W. R. Green, L. D. Fast, and R. J. Noelle. 1994. Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease. J. Clin. Invest. 94:1333.
37. Sprent, J., and J. F. Miller. 1972. Thoracic duct lymphocytes from nude mice: migratory properties and life-span. Eur. J. Immunol. 2:384.
38. Sprent, J., and J. F. Miller. 1976. Effect of recent antigen priming on adoptive immune responses. III. Antigen-induced selective recruitment of subsets of recirculating lymphocytes reactive to H-2 determinants. J. Exp. Med. 143:585.
39. Sprent, J., and H. von Boehmer. 1976. Activation of T lymphocytes to M locus determinants in vivo. I. Quantitation of T cell proliferation and migration into thoracic duct lymph. Eur. J. Immunol. 6:352.
40. + T cell contact-dependent activation of monocyte interleukin-1 synthesis. Eur. J. Immunol. 24:3148.
41. Tao, X., and R. D. Stout. 1993. T cell-mediated cognate signaling of nitric oxide production by macrophages. Requirements for macrophage activation by plasma membranes isolated from T cells. Eur. J. Immunol. 23:2916.
42. Stout, R. D., J. Suttles, J. C. Xu, I. S. Grewal, and R. A. Flavell. 1996. Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J. Immunol. 156:8.
43. Tian, L., R. J. Noelle, and D. A. Lawrence. 1995. Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1. Eur. J. Immunol. 25:306.
44. Vallera, D. A., and B. R. Blazar. 1989. T cell depletion for graft-versus-host-disease (GVHD) prophylaxis: a perspective on engraftment in mice and humans. Transplantation 47:751.
45. Blazar, B. R., P. A. Taylor, P. S. Linsley, and D. A. Vallera. 1994. In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex (MHC) barrier in mice. Blood 83:3815.
46. Blazar, B. R., C. C. B. Soderling, G. C. Koo, and D. A. Vallera. 1988. Absence of a facilitory role for NK 1.1 positive donor cells in engraftment across a major histocompatibility barrier in mice. Transplantation 45:876.
47. + cells. J. Exp. Med. 180:307.
48. Komgold, R., and J. R. Bennink. 1984. Collection of mouse thoracic duct lymphocytes. Methods Enzymol. 108:270.
49. Blazar, B. R., R. Hirsch, R. E. Gress, S. F. Carroll, and D. A. Vallera. 1991. In vivo administration of monoclonal antibodies or immunotoxins in murine recipients of allogeneic T-cell depleted marrow for the promotion of engraftment. J. Immunol. 147:1492.
50. Taswell, C. 1981. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 126:1614.
51. Blazar, B. R., S. F. Carroll, and D. A. Vallera. 1991. Prevention of murine graft versus host disease and bone marrow alloengraftment across the MHC barrier following donor graft preincubation with anti-LFA1 immunotoxin. Blood 78: 3093.
52. Panoskaltsis-Mortari, A., and R. P. Bucy. 1995. In situ hybridization with digoxigenin-labeled RNA probes: facts and artifacts. Biotechniques 18:300.
53. Bucy, R. P., A. Panoskaltsis-Mortari, G. Q. Huang, J. Li, L. Karr, M. Ross, J. H. Russell, K. M. Murphy, and C. T. Weaver. 1994. Heterogeneity of single cell cytokine gene expression in clonal T cell. J. Exp. Med. 180:1251.
54. Mantel, N. 1966. Evaluation of survival data in two new rank order statistics arising in its consideration. Cancer Chemother. Rep. 50:163.
55. Grewal, I. S., J. C. Xu, and R. A Flavell. 1995. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378:617.
56. Griggs, N. D., S. S. Agersborg, R. J. Noelle, J. A. Ledbetter, P. S. Linsley, and K. S. K. Tung. 1996. The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells. J. Exp. Med. 183:801.
57. Borrow, P., A. Tishon, S. Lee, J. C. Xu, I. S. Grewal, M. B. A. Oldstone, and R. A. Flavell. 1996. CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8(+) CTL response. J. Exp. Med. 183:2129.
58. Larsen, C. P., E. T. Elwood, D. Z. Alexander, S. C. Ritchie, R. Hendrix, C. Tuckerburden, H. R. Cho, A. Aruffo, D. Hollenbaugh, P. S. Linsley, K. J. Winn, and T. C. Pearson. 1996. Long-term acceptance of skin and cardiac alloarafts after blocking CD40 and CD28 pathways. Nature 381:434.
59. + lymphoid engraftment. J. Immunol. 152:1004.
60. + donor T cells fail to induce experimental acute graft-versus-host disease. J. Immunol. 155:585.
61. Kato, T., R. Hakamada, H. Yamane, and H. Nariuchi. 1996. Induction of IL-12 p40 messenger RNA expression and IL-12 production of macrophages via CD40-CD40 ligand interaction. J. Immunol. 156:3932.
62. Stuber, E., W. Strober, and M. Neurath. 1996. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J. Exp. Med. 183:693.
63. Chouaib, S., J. Chehimi, L. Bani, N. Genetet, T. Tursz, F. Gay, G. Trinchien, and F. Mami-Chouaib. 1994. Interleukin 12 induces the differentiation of major histocompatibility complex class I-primed cytotoxic T-lymphocyte precursors into allospecific cytotoxic effectors. Proc. Natl. Acad. Sci. USA 91:12659.
64. Oxenius, A., K. A. Campbell, C. R. Maliszewski, T. Kishimoto, H. Kikutani, H. Hengartner, R. M. Zinkernagel, and M. F. Bachmann. 1996. CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4(+) T cell functions. J. Exp. Med. 183:2209.
65. Piguet, P. F., G. E. Grau, B. Allet, and P. Vassalli. 1987. Tumor necrosis factor/ cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease. J. Exp. Med. 166:1280.
66. Nestel, F. P., K. S. Price, T. A. Seemayer, and W. S. Lapp. 1992. Macrophage priming and lipopolysacchande-triggered release of tumor necrosis factor alpha during graft-versus-host disease. J. Exp. Med. 175:405.
67. Hoffman, R. A., J. M. Langrehr, S. M. Wren, K. E. Dull, S. T. Ildstad, S. A. McCarthy, and R. L. Simmons. 1993. Characterization of the immunosuppressive effects of nitric oxide in graft vs host disease. J. Immunol. 151:1508.
68. Falzarano, G., W. Krenger, K. M. Snyder, J. Delmonte, Jr., M. Karandikar, and J. L. M. Ferrara. 1996. Suppression of B-cell proliferation to lipopolysaccharide is mediated through induction of the nitric oxide pathway by tumor necrosis factor-α in mice with acute graft-versus-host disease. Blood 87:2853.
69. Xun, C. Q., J. S. Thompson, C. D. Jennings, S. A. Brown, and M. B. Widmer. 1994. Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice. Blood 83:2360.
70. Blazar, B. R., P. A. Taylor, A. Panoskaltsis-Mortari, G. S. Gray, and D. A. Vallera. 1995. Co-blockade of the LFA1:ICAM and CD28/B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully MHC disparate donor grafts. Blood 85:2607.
71. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Tanger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease. Cell 80:707.
72. Freeman G. J., V. A. Boussiotis, A. Anumanthan, G. M. Bernstein, X. Y. Ke, P. D. Rennert, G. S. Gray, J. G. Gribben, and L. M. Nadler. 1995. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2:523.
73. Schultz, K. R., J. Paquet, S. Bader, and K. T. HayGlass. 1995. Requirement for B cells in T cell priming to minor histocompatibility antigens and development of graft-versus-host disease. Bone Marrow Transplant. 16:289.
74. Fuchs, E. J., and P. Matzinger. 1992. B cells turn off virgin but not memory T cells. Science 258:1156.
75. Epstein, M. M., F. Di Rosa, D. Jankovic, A. Sher, and P. Matzinger. 1995. Successful T cell priming in B cell-deficient mice. J. Exp. Med. 182:915.
76. van Essen, D., H. Kikutani, and D. Gray. 1995. CD40 ligand-transduced co-stimulation of T-cells in the development of helper function. Nature 378:620.
77. Foy, T. M., D. M. Page, T. J. Waldschmidt, A. Schoneveld, J. D. Laman, S. R. Masters, L. Tygrett, J. A. Ledbetter, A. Aruffo, E. Classen, J. C. C. Xu, R. A. Flavell, S. Oehen, S. M. Hedrick, and R. J. Noelle. 1995. An essential role for gp39, the ligand for CD40, in thymic selection. J. Exp. Med. 182:1377.